Keith Michael Gottesdiener - Oct 19, 2022 Form 3 Insider Report for Prime Medicine, Inc. (PRME)

Role
President and Chief Executive Officer. Exhibit 24 - Power of Attorney, Director
Signature
/s/ Carman Alenson attorney-in-fact
Stock symbol
PRME
Transactions as of
Oct 19, 2022
Transactions value $
$0
Form type
3
Date filed
10/19/2022, 08:04 PM
Previous filing
May 27, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PRME Common Stock 2.57M Oct 19, 2022 Direct
holding PRME Common Stock 32.2K Oct 19, 2022 By Spouse
holding PRME Common Stock 1.31M Oct 19, 2022 By Gottesdiener Family GST Trust F1
holding PRME Common Stock 450K Oct 19, 2022 By Coolidge GST Trust-2022 F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PRME Stock Option (right to buy) Oct 19, 2022 Common Stock 241K $3.67 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by the Gottesdiener Family GST Trust. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
F2 Shares held by the Coolidge GST Trust-2022. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.
F3 1/48th of the shares underlying this option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 27, 2021, subject to the Reporting Person's continued service on each such vesting date.

Remarks:

President and Chief Executive Officer. Exhibit 24 - Power of Attorney